Literature DB >> 32173167

The role of NLRP3 inflammasome in infection-related, immune-mediated and autoimmune skin diseases.

Dan Wang1, Brittany Duncan2, Xizhe Li3, Jian Shi4.   

Abstract

Inflammasomes are large intracellular multi-protein signaling complexes which are responsible for the activation of inflammatory responses. Among multifarious subtypes of inflammasomes, NLRP3 has been associated with a variety of inflammatory and autoimmune skin conditions, including dermatophytosis, psoriasis, acne, urticaria and bullous pemphigoid and other different skin diseases which have been a subject of intensive investigation. NLRP3 is considered to be a sensor of microbial and other danger signals and plays a crucial role in immune responses, dysregulation of NLRP3 inflammasome activation is involved in skin diseases. With the in-depth research, targeting NLRP3 inflammasome and its downstream signaling will provide new insights into the development of future therapeutic strategies. In this review, we summarize the molecular mechanism of NLRP3 inflammasome activation as well as the current knowledge on the contribution of the NLRP3 inflammasome in infection-related, immune-mediated and autoimmune skin diseases.
Copyright © 2020 Japanese Society for Investigative Dermatology. All rights reserved.

Entities:  

Keywords:  Bullous pemphigoid; Dermatophytosis; NLRP3 inflammasome; Psoriasis; Skin diseases; Skin photoaging; Urticarial; Wound healing

Mesh:

Substances:

Year:  2020        PMID: 32173167     DOI: 10.1016/j.jdermsci.2020.03.001

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  13 in total

Review 1.  Progress in Intradermal and Transdermal Gene Therapy with Microneedles.

Authors:  Ting Zhu; Wenya Zhang; Pengju Jiang; Shuwen Zhou; Cheng Wang; Lin Qiu; Honglei Shi; Pengfei Cui; Jianhao Wang
Journal:  Pharm Res       Date:  2022-08-25       Impact factor: 4.580

2.  Cell-free fat extract protects septic lethality via restraining NLRP3 inflammasome activation.

Authors:  Dingyu Wu; Xizhe Li; Xiangsheng Wang; Dan Wang
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 3.  Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent Progress.

Authors:  Ana M Giménez-Arnau; Andaç Salman
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

Review 4.  Nod-Like Receptors in Host Defence and Disease at the Epidermal Barrier.

Authors:  Judit Danis; Mark Mellett
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

5.  [Mechanism and material basis of Lianhua Qingwen capsule for improving clinical cure rate of COVID-19: a study based on network pharmacology and molecular docking technology].

Authors:  Haiyan Yan; Chuncai Zou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

6.  The Effects of Divalent Cation-Chelated Prion Fibrils on the Immune Response of EOC 13.31 Microglia Cells.

Authors:  Huan-I Jen; Zih-You Lin; Jin-Xun Guo; Cheng-I Lee
Journal:  Cells       Date:  2020-10-13       Impact factor: 6.600

7.  Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions through NLRP3 Inflammasome Activation in Macrophages.

Authors:  Bhakta Prasad Gaire; Chi-Ho Lee; Wondong Kim; Arjun Sapkota; Do Yup Lee; Ji Woong Choi
Journal:  Cells       Date:  2020-07-22       Impact factor: 6.600

8.  PKA and Epac1 Reduce Nek7 to Block the NLRP3 Inflammasome Proteins in the Retinal Vasculature.

Authors:  Li Liu; Youde Jiang; Jena J Steinle
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

Review 9.  The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review.

Authors:  Magdalena Ciążyńska; Irmina Olejniczak-Staruch; Dorota Sobolewska-Sztychny; Joanna Narbutt; Małgorzata Skibińska; Aleksandra Lesiak
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

10.  Microneedle-assisted genome editing: A transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders.

Authors:  Tao Wan; Qi Pan; Yuan Ping
Journal:  Sci Adv       Date:  2021-03-10       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.